These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 3298410

  • 1. Treatment of chronic delta hepatitis with alpha-2 recombinant interferon.
    Rizzetto M, Rosina F, Saracco G, Bellando PC, Actis GC, Bonino F, Smedile A, Trinchero P, Sansalvadore F, Pintus C.
    J Hepatol; 1986; 3 Suppl 2():S229-33. PubMed ID: 3298410
    [Abstract] [Full Text] [Related]

  • 2. Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis.
    Rosina F, Saracco G, Lattore V, Quartarone V, Rizzetto M, Verme G, Trinchero P, Sansalvadore F, Smedile A.
    Prog Clin Biol Res; 1987; 234():299-303. PubMed ID: 3628384
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of chronic delta infection with recombinant human interferon alpha 2c at high doses.
    Porres JC, Carreño V, Bartolomé J, Moreno A, Galiana F, Quiroga JA.
    J Hepatol; 1989 Nov; 9(3):338-44. PubMed ID: 2691569
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of hepatitis delta virus (HDV) replication by lymphoblastoid human alpha interferon.
    Thomas HC, Farci P, Shein R, Karayiannis P, Smedile A, Caruso L, Gerin J.
    Prog Clin Biol Res; 1987 Nov; 234():277-90. PubMed ID: 3628382
    [Abstract] [Full Text] [Related]

  • 5. Natural killer cell function during interferon treatment of delta hepatitis.
    Actis GC, Maran E, Saracco G, Rosina F, Baldi M, Brunetto M.
    Prog Clin Biol Res; 1987 Nov; 234():305-8. PubMed ID: 3628385
    [No Abstract] [Full Text] [Related]

  • 6. Alpha interferon therapy in children with chronic active hepatitis B and delta virus infection.
    Kay MH, Wyllie R, Deimler C, Caulfield M, Steffen R, Baetz-Greenwalt B.
    J Pediatr; 1993 Dec; 123(6):1001-4. PubMed ID: 8229507
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of chronic hepatitis due to hepatitis B virus.
    Sherlock S, Thomas HC.
    Lancet; 1985 Dec 14; 2(8468):1343-6. PubMed ID: 2866396
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M, Pântea V, Cebotarescu V, Cojuhari L, Jimbei P, Albrecht J, Schmid P, Le Gal F, Gordien E, Krawczyk A, Mijočević H, Karimzadeh H, Roggendorf M, Vaillant A.
    Lancet Gastroenterol Hepatol; 2017 Dec 14; 2(12):877-889. PubMed ID: 28964701
    [Abstract] [Full Text] [Related]

  • 14. Interferon therapy of chronic hepatitis B virus infection in Chinese.
    Lok AS, Lai CL, Wu PC.
    J Hepatol; 1986 Dec 14; 3 Suppl 2():S209-15. PubMed ID: 3036936
    [Abstract] [Full Text] [Related]

  • 15. Recombinant leucocyte interferon treatment of chronic hepatitis B. An analysis of two therapeutic trials.
    Dusheiko GM, Paterson AC, Pitcher L, Kassianides C, DiBisceglie AM, Song E, Kew MC.
    J Hepatol; 1986 Dec 14; 3 Suppl 2():S199-207. PubMed ID: 3298408
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
    Manesis EK, Vourli G, Dalekos G, Vasiliadis T, Manolaki N, Hounta A, Koutsounas S, Vafiadis I, Nikolopoulou G, Giannoulis G, Germanidis G, Papatheodoridis G, Touloumi G.
    J Hepatol; 2013 Nov 14; 59(5):949-56. PubMed ID: 23850875
    [Abstract] [Full Text] [Related]

  • 17. Serum immunoglobulin M antibody to hepatitis D as a surrogate marker of hepatitis D in interferon-treated patients and in patients who underwent liver transplantation.
    Borghesio E, Rosina F, Smedile A, Lagget M, Niro MG, Marinucci G, Rizzetto M.
    Hepatology; 1998 Mar 14; 27(3):873-6. PubMed ID: 9500721
    [Abstract] [Full Text] [Related]

  • 18. Treatment of chronic delta hepatitis with recombinant human alpha interferon.
    Hoofnagle J, Mullen K, Peters M, Avigan M, Park Y, Waggoner J, Gerin J, Hoyer B, Smedile A.
    Prog Clin Biol Res; 1987 Mar 14; 234():291-8. PubMed ID: 3628383
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.